Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

27%

6 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (14)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (5)

Trial Status

Completed14
Recruiting5
Not Yet Recruiting2
Terminated1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT04907643Not ApplicableRecruiting

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT07209566Not ApplicableRecruiting

A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Women With and Without Dysmenorrhea (Painful Periods).

NCT06978673Not ApplicableNot Yet Recruiting

Neurolytic Block Techniques In Abdominal Visceral Cancer Pain

NCT06973122Not ApplicableRecruitingPrimary

Paragastric Neural Blockade and Laparoscopic Assisted Transversus Abdominis Plane Block on Visceral Pain After Surgery

NCT06753500Phase 4RecruitingPrimary

Intraoperative Autonomic Blockade for Laparoscopic Cholecystectomy

NCT06517069Not ApplicableRecruitingPrimary

Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients

NCT06367660Phase 4Not Yet RecruitingPrimary

Comparison Between Hyperbaric Bupivacaine With Fentanyl vs. Hyperbaric Bupivacaine With Dexmedetomidine in Reducing Visceral Pain During Cesarean Delivery Under Spinal Anaesthesia

NCT04671628Not ApplicableCompleted

Effects of a 2-week Relaxing Music Intervention on Anxiety, Stress, and Gut Symptoms in Aerobic Exercisers

NCT06031129Not ApplicableCompletedPrimary

Butorphanol in Pain Following Ablation for Hepatic Tumor

NCT02214550Phase 4Completed

Chronic Pain Risk Associated With Menstrual Period Pain

NCT05491187Phase 3CompletedPrimary

Comparison Between Bupivacaine With and Without Fentanyl in Reducing Pain During Cesarean Delivery Under Spinal Anaesthesia

NCT05353426Not ApplicableCompletedPrimary

Paragastric Autonomic Blockade to Prevent Visceral Pain After Laparoscopic Sleeve Gastrectomy

NCT03357029Not ApplicableCompleted

Neuromodulation in Patients With Painful Chronic Pancreatitis

NCT02291445Phase 2Completed

Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study

NCT04592718Not ApplicableCompleted

Four-week Breathing Interventions on Gut Symptoms, Heart Rate Variability, and Psychological Measures in Runners

NCT02551029Not ApplicableCompleted

fMRI and Visceral Perception Upon Capsaicin Infusion

NCT02497196Not ApplicableCompletedPrimary

Neurophysiological Effects on tPCS and tDCS on Healthy Subjects and on Patients With Chronic Visceral Pain

NCT03798522Not ApplicableCompleted

Erector Spinae Plane Block Versus Opioid Based General Anesthesia During Laparoscopic Bariatric Surgery

NCT03314792Phase 4Completed

Effects of Tapentadol Versus Oxycodone After Hysterectomy.

NCT03765801Phase 1Completed

A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on it

Scroll to load more

Research Network

Activity Timeline